453
Participants
Start Date
February 22, 2018
Primary Completion Date
July 27, 2022
Study Completion Date
November 25, 2024
Bovine Lactoferrin
Intervention includes a daily dose of 200 mg/kg bovine lactoferrin in breast/donor human milk or formula milk until 34 weeks corrected gestation or for a minimum of 2 weeks, whichever is longer, or until discharge home or transfer, if earlier.
No Bovine Lactoferrin added
Control includes daily study feed with no bovine lactoferrin added in breast/donor human milk or formula milk until 34 weeks corrected gestation or for a minimum of 2 weeks, whichever is longer, or until discharge home or transfer, if earlier.
Foothills Medical Centre, Calgary
Children's and Women's Health Centre BC, Vancouver
Health Sciences Centre Winnipeg, Winnipeg
Saint Boniface Hospital, Winnipeg
IWK Health Centre, Halifax
McMaster Children's Hospital, Hamilton
The Ottawa Hospital, Ottawa
Mount Sinai Hospital, Toronto
Sunnybrook Health Sciences Centre, Toronto
Sunnybrook Research Institute (Toronto, Ontario)
UNKNOWN
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
National Health and Medical Research Council, Australia
OTHER
Dr. Elizabeth Asztalos
OTHER